Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • News & Developments
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • News & Developments
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Data Protection policies
  • Cookies Policy
  • Supplier Code of Conduct
  • Modern Slavery and Human Trafficking Statement
  • Contact Us
  • home
  • Market Intelligence
  • Search

Your search for ‘Cadila Healthcare Ltd.’ returned 30 results

Use advanced search filters to refine your search

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    ´Cadila´ Contention Crashes!

    Commercial viability, reputation, brand association and like aspects often leave trademark owners worrisome. The extent of concern rises, when the mark under threat associates itself with higher levels of health and well-being. Not only do issues of quality and content come to light, but more so does the fear of misuse by closely associated industries come to play.
    IndiaLitigation, Mediation & Arbitration
    Lex Orbis
    Lex Orbis
  • Article

    Medicines Patent Pool's Voluntary Licensing; Unique In Its Efforts To Better Treat The Infection

    Efforts of Medicines Patent Pool (hereinafter referred to as "MPP"); a United Nations backed public health organisation, founded in July 2010, and based in Geneva, Switzerland are praiseworthy.
    IndiaIntellectual Property
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    Passing Off Pharmaceutical Products

    Passing off, a form of tort, the substantive law of which is based on common law with the object of protecting some form of property is no where defined in the Trade Marks Act, 1999 though is referred to in ss. 27(2), 134(1)(c) and 135.
    IndiaIntellectual Property
    Lex Orbis
    Lex Orbis
  • Article

    The SUGAR-FREE Case: "Determination of Distinctiveness in Coined Terms"

    Establishing ‘distinctiveness’ of coined words is tackled by Courts on a case-to-case basis.
    IndiaIntellectual Property
    Lex Orbis
    Lex Orbis
  • Article

    Addressing Confusion Amongst Pharmaceutical Trademarks

    A trademark is not simply a mark or a visual symbol that denotes the proprietor or the quality of a product, but goes far as crystallizing customer loyalty even after the expiration of a patent term for a medicament.
    IndiaIntellectual Property
    Intepat IP
    Intepat IP
  • Article

    Bevatas Is Distinct From Bevetex, Rules Delhi HC

    In January 2020, Delhi High Court dismissed an appeal by Sun Pharma Laboratories against an order passed by the trial court whereby the latter...
    IndiaIntellectual Property
    Lex Orbis
    Lex Orbis
  • Article

    Delhi High Court Bars Use Of 'Vigoura' To Protect Pfizer's Brand 'Viagra'

    The Delhi High Court, through its judgment in the case of Pfizer Products Inc. v. Renovision Exports Pvt. Ltd. and Anr CS(COMM) 378/2018, dated May 1, 2024, has decreed the suit in favour of the US-based drug major Pfizer Products Inc.
    IndiaIntellectual Property
    Lex Orbis
    Lex Orbis
  • Article

    Balancing Competition Law: Supreme Court's Verdict In Schott Glass Case

    In a significant judgment delivered on May 13, 2025, the Supreme Court of India dismissed the appeals filed by the Competition Commission of India (CCI) and Kapoor Glass India Pvt. Ltd., upholding the decision...
    IndiaAntitrust/Competition Law
    IndiaLaw LLP
    IndiaLaw LLP
  • Article

    How The Thin Line Between Generic And Unique Terms Challenge Pharmaceutical Trademark Boundaries

    Pharmaceutical companies invest billions in developing and marketing drugs, while supporting the rigorous testing and regulatory approval processes required to ensure safety and efficacy of these life-saving therapies.
    IndiaIntellectual Property
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    Trademark Enforcement And Public Interest In Pharmaceutical Disputes: The Delhi High Court’s Approach In Novo Nordisk A/S v. Dr. Reddy’s Laboratories Ltd

    The case raises a central question: to what extent can public interest influence the grant and scope of injunctive relief in cases involving deceptively similar medicinal trademarks?
    IndiaIntellectual Property
    Dentons
    Dentons
  • Article

    Injunctions Against Sale Of Lingaliptin

    The plaintiff is a multinational company involved in the production and manufacture of pharmaceutical drugs and had acquired patent rights for its products under Indian Patent Nos. 243301 and 227719.
    IndiaIntellectual Property
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    Seven Towns V. Kiddland: Delhi High Court On Trade Dress Protection

    The concept of trade dress, although closely associated with trademarks is not explicitly recognized in Indian legislations unlike its U.S.A. counterpart.
    IndiaIntellectual Property
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    "VOLVO" For Ice-Cream Disallowed

    The recent case of Aktiebolaget Volvo & ors v. Vinod Kumar & ors. involved the question of whether Vinod Kumar (Defendants) could be held guilty of infringement or passing off by selling its ice-creams under the Plaintiffs brand name "VOLVO".
    IndiaIntellectual Property
    Lex Orbis
    Lex Orbis
  • Article

    Appeals Against Pre-grant Patent Oppositions And Exhaustion Of Remedies

    Patent laws, including in India, usually allow oppositions to be filed against patent applications, either before or after they are granted.
    IndiaIntellectual Property
    Obhan Mason
    Obhan Mason
  • Article

    Trademark Infringement In The Pharmaceutical Sector

    India's pharmaceutical industry is prospering, with tremendous expansion over the last few decades. The Indian government is working hard to promote this business by enacting and implementing laws...
    IndiaIntellectual Property
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    Trademark Infringement In India's Pharmaceutical Companies

    Trademark Infringement In India's pharmaceutical Companies is prospering, with tremendous expansion over the last few decades.
    IndiaIntellectual Property
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    PTAB Institutes Kyle Bass Lialda Patent IPR

    After filing over thirty petitions for Inter Partes Review of Orange Book-listed patents for various drugs, Kyle Bass and his Coalition for Affordable Drugs finally have made it over the first hurdle.
    United StatesIntellectual Property
    Foley & Lardner LLP
    Foley & Lardner LLP
  • Article

    CANDID vs. CANDEX-B Judgment: A Conundrum!

    In the present case, Karlin Pharmaceuticals & Exports (first respondent) had filed Application No.749366 dated March 21, 1997 (on a proposed to be used basis), seeking registration of the trademark ‘CANDEX-B' for pharmaceutical products in class 5.
    IndiaIntellectual Property
    S.S. Rana & Co.
    S.S. Rana & Co.
  • Article

    The Supreme Court Of India Reinforces Effects-based Standards In Establishing Abuse Of Dominance

    In a pivotal ruling for India's competition law regime, the Hon'ble Supreme Court of India ("SC"), in Competition Commission of India v. Schott Glass India Pvt. Ltd. & Anr...
    IndiaAntitrust/Competition Law
    CMS INDUSLAW
    CMS INDUSLAW
  • Article

    The 'Wow' Factor: Section 11 And the Jurisprudence of Trademark Confusion in Food Brands

    India's‍‌‍‍‌‍‌‍‍‌ food sector is growing fast, and the competition of the brand identity has become very intense. Quick service restaurants, food delivery platforms, and cloud kitchens are the major players in the market.
    IndiaIntellectual Property
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Showing 1–20 of 30 results

    Next
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics